idarubicin has been researched along with Skin Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anacak, Y; Aydinok, Y; Balkan, C; Delcastello, BE; Kamer, SA; Karadaş, N; Karapinar, DY; Kavakli, K | 1 |
Hsu, CH; Liu, CI | 1 |
Jensen, PB; Langer, SW; Sehested, M | 1 |
3 other study(ies) available for idarubicin and Skin Diseases
Article | Year |
---|---|
Successful Treatment With Total Skin Electron Beam Therapy in a Child With Isolated Cutaneous Relapsed AML.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Electrons; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Skin Diseases; Vidarabine | 2015 |
Leukaemia cutis at the site of striae distensae: an isotopic response?
Topics: Antineoplastic Combined Chemotherapy Protocols; Atrophy; Biopsy; Cytarabine; Female; Humans; Idarubicin; Leukemia; Middle Aged; Skin; Skin Diseases; Skin Neoplasms; Treatment Outcome | 2010 |
Treatment of anthracycline extravasation with dexrazoxane.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Extravasation of Diagnostic and Therapeutic Materials; Female; Idarubicin; Mice; Razoxane; Skin Diseases; Topoisomerase II Inhibitors | 2000 |